HRTX - Heron Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
Total Revenue
116,891
Cost of Revenue
47,698
Gross Profit
69,193
Operating Expenses
Research Development
154,709
Selling General and Administrative
124,057
Total Operating Expenses
278,766
Operating Income or Loss
-209,573
Interest Expense
-
Total Other Income/Expenses Net
5,141
Income Before Tax
-201,139
Income Tax Expense
-
Income from Continuing Operations
-201,139
Net Income
-201,139
Net Income available to common shareholders
-201,139
Reported EPS
Basic
-
Diluted
-
Weighted average shares outstanding
Basic
-
Diluted
-
EBITDA
-